Transversus Abdominis Plane Block for Laparoscopic Appendicectomy in Children
NCT ID: NCT02505841
Last Updated: 2015-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
240 participants
INTERVENTIONAL
2015-05-31
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transversus Abdominis Plane Versus Caudal Block for Pediatrics
NCT02398123
Transversus Abdominis Plane Block in Acute Appendicitis Pain Managment
NCT05004532
Laparoscopic Guided Transversus Abdominis Plane Block for Postoperative Analgesia After Pediatric Laparoscopic Surgery.
NCT03388671
Lap-guided vs Us-guided TAP Block in Pediatric Laparoscopy
NCT05737394
TAP Block for Laparoscopic Appendicectomy in Adults
NCT03252561
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Curare: Atracurium injection at 0.5 mg/kg
Curare
Atracurium injection at 0.5 mg/kg at least 3 minutes before the surgical incision
Group 2
TAP block and curare: Ultrasound-guided transversus abdominis plane block wih Ropivacaine injection 0.2% at 0.3 ml/kg then atracurium injection at 0.5 mg/kg
TAP block with Ropivacaine
Ultrasound-guided transversus abdominis plane block wih Ropivacaine injection 0.2% at 0.3 ml/kg
Curare
Atracurium injection at 0.5 mg/kg at least 3 minutes before the surgical incision
Group 3
TAP block: Ultrasound-guided transversus abdominis plane block wih Ropivacaine injection 0.2% at 0.3 ml/kg
TAP block with Ropivacaine
Ultrasound-guided transversus abdominis plane block wih Ropivacaine injection 0.2% at 0.3 ml/kg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TAP block with Ropivacaine
Ultrasound-guided transversus abdominis plane block wih Ropivacaine injection 0.2% at 0.3 ml/kg
Curare
Atracurium injection at 0.5 mg/kg at least 3 minutes before the surgical incision
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient whose general state corresponds to the classification of the American Society of Anesthesiologists (ASA) I to II
* Patient member in a national insurance scheme
Exclusion Criteria
* Patient with a contraindication to local anesthesics
* Patient with a contraindication to TAP block
* Patient with allergies or known hypersensitivity to curare
1 Year
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maud MM Maniora, MD
Role: PRINCIPAL_INVESTIGATOR
Montpellier University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU Montpellier
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-A01431-46
Identifier Type: REGISTRY
Identifier Source: secondary_id
9488
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.